Preemptive interferon-α treatment could protect against relapse and improve long-term survival of ALL patients after allo-HSCT
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preemptive interferon-α treatment could protect against relapse and improve long-term survival of ALL patients after allo-HSCT
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-11-19
DOI
10.1038/s41598-020-77186-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunotherapy for the Treatment of Acute Lymphoblastic Leukemia
- (2020) Valentin Barsan et al. Current Oncology Reports
- Prognostic factors and long‐term follow‐up of basiliximab for steroid‐refractory acute graft‐versus‐host disease : Updated experience from a large‐scale study
- (2020) Si‐Ning Liu et al. AMERICAN JOURNAL OF HEMATOLOGY
- Donor-Derived CD19-Targeted T Cell Infusion Eliminates B Cell Acute Lymphoblastic Leukemia Minimal Residual Disease with No Response to Donor Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation
- (2019) Yifei Cheng et al. Engineering
- Minimal residual disease-directed immunotherapy for high-risk myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation
- (2019) Xiaodong Mo et al. Frontiers of Medicine
- The prognostic significance of Wilms’ tumor gene 1 (WT1) expression at diagnosis in adults with Ph-negative B cell precursor acute lymphoblastic leukemia
- (2019) Ya-Zhen Qin et al. ANNALS OF HEMATOLOGY
- Comparison of the clinical outcomes of hematologic malignancies after myeloablative haploidentical transplantation with G-CSF/ATG and posttransplant cyclophosphamide: results from the Chinese Bone Marrow Transplantation Registry Group (CBMTRG)
- (2019) Feifei Tang et al. Science China-Life Sciences
- Management of cytokine release syndrome related to CAR-T cell therapy
- (2019) Hongli Chen et al. Frontiers of Medicine
- Effects of preemptive interferon-α monotherapy in acute leukemia patients with relapse tendency after allogeneic hematopoietic stem cell transplantation: a case-control study
- (2018) Xiao-Ji Lin et al. ANNALS OF HEMATOLOGY
- Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
- (2018) Gerrit J. Schuurhuis et al. BLOOD
- The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology
- (2018) Lanping Xu et al. Journal of Hematology & Oncology
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
- (2018) Jae H. Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interferon-α salvage treatment is effective for patients with acute leukemia/myelodysplastic syndrome with unsatisfactory response to minimal residual disease-directed donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation
- (2018) Xiaodong Mo et al. Frontiers of Medicine
- The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China
- (2018) Yu Wang et al. CANCER LETTERS
- Chimeric Antigen Receptor T-Cell Therapy
- (2018) Ndiya Ogba et al. Journal of the National Comprehensive Cancer Network
- Interferon‐α Is Effective for Treatment of Minimal Residual Disease in Patients with t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Registry Study
- (2018) Xiao‐Dong Mo et al. ONCOLOGIST
- Comparison analysis between haplo identical stem cell transplantation and matched sibling donor stem cell transplantation for high-risk acute myeloid leukemia in first complete remission
- (2018) Yang Liu et al. Science China-Life Sciences
- The role of collateral related donors in haploidentical hematopoietic stem cell transplantation
- (2018) Xiao-Dong Mo et al. Science Bulletin
- Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
- (2018) Sebastian Giebel et al. BONE MARROW TRANSPLANTATION
- Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia
- (2018) S. Modvig et al. LEUKEMIA
- Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effect
- (2017) Guillermo Orti et al. EXPERIMENTAL HEMATOLOGY
- Sustaining integrating imatinib and interferon-α into maintenance therapy improves survival of patients with Philadelphia positive acute lymphoblastic leukemia ineligible for allogeneic stem cell transplantation
- (2016) Pu Kuang et al. LEUKEMIA & LYMPHOMA
- Second cord blood transplantation and interferon-α maintenance therapy for relapsed Ph+ acute lymphoblastic leukemia with the T315I mutation
- (2016) Masahiko Sumi et al. LEUKEMIA & LYMPHOMA
- Interferon-α: A Potentially Effective Treatment for Minimal Residual Disease in Acute Leukemia/Myelodysplastic Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation
- (2015) Xiao-Dong Mo et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study
- (2015) Yu Wang et al. BLOOD
- CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
- (2015) S. L. Maude et al. BLOOD
- Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation
- (2015) C-H Yan et al. BONE MARROW TRANSPLANTATION
- Who is the best donor for a related HLA haplotype-mismatched transplant?
- (2014) Y. Wang et al. BLOOD
- Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
- (2014) P. Armand et al. BLOOD
- Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificity
- (2013) Xiao-su Zhao et al. ANNALS OF HEMATOLOGY
- Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation
- (2012) C.-H. Yan et al. BLOOD
- Diagnosis and management of acute graft-versus-host disease
- (2012) Fiona L. Dignan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Diagnosis and management of chronic graft-versus-host disease
- (2012) Fiona L. Dignan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Human interferon-alpha increases the cytotoxic effect of CD56+cord blood-derived cytokine-induced killer cells on human B-acute lymphoblastic leukemia cell lines
- (2012) Ludovic Durrieu et al. CYTOTHERAPY
- Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemia
- (2012) Huan Chen et al. Journal of Hematology & Oncology
- Successful treatment of first and second recurrence of acute lymphoblastic leukemia after related allogeneic bone marrow transplant at unusual sites using single-dose vincristine followed by interferon-α2b and granulocyte-macrophage colony-stimulating factor
- (2012) Leonid Volodin et al. LEUKEMIA & LYMPHOMA
- Wilms’ tumor gene 1 expression: an independent acute leukemia prognostic indicator following allogeneic hematopoietic SCT
- (2011) X-S Zhao et al. BONE MARROW TRANSPLANTATION
- Interferon-α in acute myeloid leukemia: an old drug revisited
- (2011) S Anguille et al. LEUKEMIA
- Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia
- (2010) S. Heesch et al. HAEMATOLOGICA
- Interferon- induces the growth inhibition of human T-cell leukaemia line Jurkat through p38 and p38
- (2010) W. H. Lee et al. JOURNAL OF BIOCHEMISTRY
- Partially Matched Related Donor Transplantation Can Achieve Outcomes Comparable with Unrelated Donor Transplantation for Patients with Hematologic Malignancies
- (2009) H. Xiao-Jun et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More